NASDAQ · FTLFHealthcarePharmaceuticals

FitLife Brands, Inc. Common Stock (FTLF)

$8.18+3.68%
Close Nov 4, 2026 · split-adjusted
Nov 2, 2026$8.03▼ 58.42% in range
Nov 3, 2025Low $7.84 · High $19.85Nov 2, 2026
What changed · written from our data
As of Nov 4, 2026

FitLife Brands closed at $8.18 on Nov 4, up 3.68%, 58.8% below its 52-week closing high. Volume of 2.2K shares was 0.15× its 20-day average (below normal).

Split-adjusted performance: -9.3% over one month, -12.1% over six months, -57.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $26.55M, up 64.6% from a year earlier, with a net margin of 7.3%.

Short interest was 59.9K shares at the Oct 15 settlement (1.6% of float, 3.9 days to cover).

Market cap$76.8M9.4M shares
Revenue · quarter$26.5M+64.6% YoY
Diluted EPS$0.20+11.1% YoY
P/E · TTM12.3×P/S 0.8×
Net margin7.3%Gross 37.0%
Dividend yieldNone
52-week range7.84 – 19.85−58.8% from high
Volume2.2K0.15× 20-day avg
Volatility · 60d46.3%Annualised
Short % of float1.6%3.9 days to cover
Net cash-$36.8MCash $1.1M
Next earnings—Not scheduled
Split-adjusted performance
1W −1.4%1M −9.3%3M −19.9%6M −12.1%YTD −49.7%1Y −57.6%3Y −27.1%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum63
Revenue growth81
Net margin77
Value (low P/E)66
Size38

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short59.9K−0.3% vs prior
Days to cover3.9Settled Oct 15
% of float1.6%
Short vol. 10d22.0%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
FTLFFitLife Brands$8.18+3.68%−12.1%+64.6%7.3%12.3$76.8M
LFVNLifevantage Corporation Common Stock (Delaware)$5.97+3.65%−0.5%−23.1%3.0%14.8$75.2MCompare
ACRVAcrivon Therapeutics$1.74+4.19%−16.7%———$74.6MCompare
COYACoya Therapeutics$3.08−0.96%−27.4%+49.0%−2723.4%—$72.3MCompare
MNOVMedicinova$1.45+2.11%0.0%+240.6%−504.8%—$71.4MCompare
PMVPPMV Pharmaceuticals$1.33−3.99%−8.6%———$70.8MCompare
MAIAMAIA Biotechnology$1.14+5.56%−15.6%———$70.4MCompare
CRBPCorbus Pharmaceuticals Holdings$3.57−7.75%−67.3%———$69.0MCompare
RLYBRallybio$15.90+0.25%+9.2%−100.0%—3.2$85.6MCompare

Quick answers

What does FitLife Brands do?
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr.
What is FTLF's market cap?
$76.82M, based on the Nov 4 close of $8.18.
What is FTLF's P/E ratio?
12.3× trailing-twelve-month earnings of $6.23M.
Does FitLife Brands pay a dividend?
No regular cash dividend has been paid in the last year.
How much of FTLF is sold short?
59.9K shares, 1.6% of float, as of Oct 15, 2026.
What sector is FTLF in?
Healthcare, in the Pharmaceuticals industry.

About FitLife Brands

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr. Tobias, MusclePharm, Irwin Naturals, Applied Nutrition, Isatori, and Nature's Secret brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

HQ: Omaha, NE81 employeesListed Sep 25, 2007fitlifebrands.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology